This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Preclinical Theranostic Profiling of [64Cu]Cu-Acetate in Prostate Cancer.
Molecules (Basel, Switzerland) · 2025
Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer.
Pharmaceutics · 2025
Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease.
Molecules (Basel, Switzerland) · 2023
Latest funding
- $696,150
High affinity inhibitors of PACE4 with therapeutic implications for prostate cancer
CIHR · 2019 · Co-investigator
- $168,000
Design, Synthesis and Characterization of Self-Assembling Nanotubes and Nanospheres
NSERC · 2017 · Principal investigator
- $25,000
Synthesis of TRIOZAN-Peptide Conjugates as Blood-Brain Transient Drug Nanovector
NSERC · 2017 · Principal investigator
6 publications.
Preclinical Theranostic Profiling of [64Cu]Cu-Acetate in Prostate Cancer.
Ghanaatgar Kasbi S, Savard M, Dubuc C, Dory Y, Guérin B, Gobeil F
Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer.
Ghanaatgar Kasbi S, Savard M, Couture F, Dubuc C, Dumulon-Perreault V, Nepveu-Traversy ME, Ait-Mohand S, Sabbagh R, Geha S, Guérin B, Dory Y, Gobeil F
Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease.
Gagnon M, Savard M, Tran TMH, Vincent L, Moquin A, Tremblay P, Roucou X, Dory Y, Gobeil F
Making Nanocomposites of Hydrophilic and Hydrophobic Polymers Using Gas-Responsive Cellulose Nanocrystals.
Farnia F, Fan W, Dory Y, Zhao Y
Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.
Łepek T, Kwiatkowska A, Couture F, Ly K, Desjardins R, Dory Y, Prahl A, Day R
Mechanism and regioselectivity of the cycloaddition of thiones derived from Meldrum's acid, malonates, or other dicarbonyls.
Perreault S, Poirier M, Léveillé P, René O, Joly P, Dory Y, Spino C
High affinity inhibitors of PACE4 with therapeutic implications for prostate cancer
Principal investigators: Day, Robert
Keywords: C23; Cancer Animal Models; Drug Delivery; Enzyme Inhibitor; Imaging; Medicinal Chemistry; Pace4; Prodrugs; Structure Activity; Theranostics
Design, Synthesis and Characterization of Self-Assembling Nanotubes and Nanospheres
Principal investigators: Dory, Yves
Synthesis of TRIOZAN-Peptide Conjugates as Blood-Brain Transient Drug Nanovector
Principal investigators: Dory, Yves
A parallel evaporator for peptides, peptidomimetics and macrocycles
Principal investigators: Marsault, Eric
Design, preparation and biological evaluation of libraries of marocyclic delta opioid receptor agonists for the treatment of pain
Principal investigators: Dory, Yves
Design, synthesis and characterization of novel enkephalin analogs for the delta opioid receptor
Principal investigators: Gendron, Louis
Keywords: Biased-Agonists; Blood-Brain-Barrier; Delta Opioid Receptor; Enkephalin; Macrocylces; Medicinal Chemistry; Pain; Peptidomimetics; Pet Tracers; Unwanted-Effects
An institutional LC-MS platform for research in pharmacology and medicinal chemistry
Principal investigators: Marsault, Eric
Peptide synthesizer for research in pharmacology and medicinal chemistry. Synthétiseur de peptides pour la recherche en pharmacologie et chimie médicinale.
Principal investigators: Dory, Yves
Theoretical design, synthesis and characterization of novel organic self-assembling materials. Conception, Synthèse et Caractérisation de Nouveaux Matériaux Auto-Assemblés.
Principal investigators: Dory, Yves
Conception, synthèse et caractérisation de peptidomimétiques agonistes des récepteurs opioïdergiques delta
Principal investigators: Gendron, Louis
Keywords: Chimie Médicinale; Douleur; Opioïdes; Peptidomimétiques; Récepteur Opioïdergique Delta; Tep
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Xavier Roucou and Yves Dory: 1 shared paper
- Xavier Roucou and Philippe Tremblay: 1 shared paper
- Robert Day and Yves Dory: 1 shared paper
- Yue Zhao and Yves Dory: 1 shared paper
- Yves Dory and Claude Spino: 1 shared paper
- Yves Dory and Philippe Tremblay: 1 shared paper
- Chimie
- Exceptional, Special Education
- Surgery
- Biochemistry
Co-authors at Université de Sherbrooke, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.